Honeycutt v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedMarch 17, 2026
Docket20-1410V
StatusPublished

This text of Honeycutt v. Secretary of Health and Human Services (Honeycutt v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Honeycutt v. Secretary of Health and Human Services, (uscfc 2026).

Opinion

In the United States Court of Federal Claims No. 20-1410V (Filed Under Seal: February 18, 2026) (Reissued: March 17, 2026) FOR PUBLICATION *************************************** MARTHA HONEYCUTT, Executrix of * ESTATE OF RAYMOND CECIL * HONEYCUTT, * * Petitioner, * * v. * * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * *************************************** Braden Blumenstiel, DuPont and Blumenstiel LLC, Dublin, OH, for Petitioner. Emily M. Hanson, Trial Attorney, Torts Branch, Civil Division, United States Department of Justice, Washington, D.C., for Respondent. Also on the briefs were Brett A. Shumate, Assistant Attorney General; C. Salvatore D’Alessio, Director, Torts Branch; Heather L. Pearlman, Deputy Director, Torts Branch; and Colleen C. Hartley, Assistant Director, Torts Branch, Civil Division, United States Department of Justice. OPINION AND ORDER Petitioner Martha Honeycutt sought relief under the National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to 34 (“Vaccine Act”), as executrix of the estate of her father, Raymond Cecil Honeycutt, who died after receiving an influenza vaccine. After a stipulation of dismissal was filed in December 2023, Petitioner’s counsel sought attorneys’ fees. The Special Master found that there was no reasonable basis for the petition after August 22, 2022, and so denied most fees incurred after that date. See Decision on Attorneys’ Fees and Costs (“Fees Decision”) (ECF 55). Petitioner’s counsel seeks review, see Mot. for Review (ECF 57); Resp. (ECF

 This Opinion was issued under seal on February 18, 2026. The parties were directed to propose redactions by March 4, 2026. No proposed redactions were submitted. The Court hereby releases publicly the Opinion and Order of February 18 in full. 61), and I have heard argument, see Tr. of Oral Arg. (“Tr.”) (ECF 67). Because the Special Master did not abuse her discretion, the motion for review is DENIED.1

BACKGROUND The Vaccine Act provides for recovery of fees and costs by counsel for petitioners. Counsel are prohibited from charging their clients anything above an award of fees and costs. 42 U.S.C. § 300aa-15(e)(3). But counsel are entitled to seek fees and costs even when their clients lose. 42 U.S.C. § 300aa-15(e)(1); James- Cornelius ex rel. E. J. v. Sec’y of Health & Hum. Servs., 984 F.3d 1374, 1379 (Fed. Cir. 2021) (citing Cloer v. Sec’y of Health & Hum. Servs., 675 F.3d 1358, 1360–61 (Fed. Cir. 2012)). Special masters may award fees to lawyers for losing petitioners if “the petition was brought in good faith and there was a reasonable basis for the claim[.]” 42 U.S.C. § 300aa-15(e)(1). “Good faith” and “reasonable basis” are separate elements. See Simmons v. Sec’y of Health & Hum. Servs., 875 F.3d 632, 635 (Fed. Cir. 2017). Only the second element, reasonable basis, is at issue here. The existence of a reasonable basis for a vaccine case is “an objective inquiry,” based solely on a retrospective evaluation of the evidence. Simmons, 875 F.3d at 636. A reasonable basis for an unsuccessful claim requires a quantum of evidence “‘lower than the preponderant evidence standard required to prove entitlement to compensation,’ but ‘more than a mere scintilla.’” James-Cornelius, 984 F.3d at 1379 (quoting Cottingham ex rel. K.C. v. Sec’y of Health & Hum. Servs., 971 F.3d 1337, 1346 (Fed. Cir. 2020)). Two aspects of the reasonable-basis standard are especially relevant here. First, counsel’s litigation decisions are irrelevant to whether a reasonable basis exists. The rush to file a petition before the statute of limitations expires, for example, does not create a reasonable basis when the facts do not support the petition. Simmons, 875 F.3d at 636. Counsel’s “desire to obtain additional evidence” is not relevant to the reasonable-basis analysis either. James-Cornelius, 984 F.3d at 1381. Reasonable basis focuses on what evidence counsel has, not what he wants. Second, a reasonable basis for a petition only lasts as long as the facts of the case justify it. For there to be any reasonable basis at all, the petitioner must have had a reasonable basis at the time the petition was filed. Cottingham, 971 F.3d at 1344. And a reasonable basis can cease to exist at any time, depending on how the facts develop. Once petitioner and counsel learn facts that eliminate a claim’s

1 This Court has jurisdiction. See 42 U.S.C. §§ 300aa-11(a), 300aa-16(a). Petitioner timely moved for

review. See 42 U.S.C. § 300aa-12(e)(1).

-2- reasonable basis, the special master can deny subsequent fees and costs. Perreira ex rel. Perreira v. Sec’y of Dep’t of Health & Hum. Servs., 33 F.3d 1375, 1377 (Fed. Cir. 1994). The net result is an ongoing duty on Vaccine Act petitioners and their lawyers to evaluate the strength of their cases. Lawyers in Vaccine Act cases — like any other lawyers — must decide on litigation strategies in consultation with their clients, based on the information available. Whether they are entitled to get paid with Vaccine Act funds for pursuing those strategies depends on what the facts objectively support. When individuals initiate Vaccine Act claims without a reasonable basis — or pursue Vaccine Act claims longer than the facts objectively call for — the lawyers risk going unpaid.

FACTS In this case, Petitioner claimed Mr. Honeycutt developed Guillain-Barré syndrome (“GBS”) after receiving his influenza vaccine. Pet. at ¶¶ 6, 13–15 (ECF 1). But a question soon arose about whether he ever had GBS at all. In June 2022, the government’s report pursuant to RCFC App. B, Rule 4(c) contended that “[Mr. Honeycutt’s] medical records fail to provide preponderant proof that he actually suffered from GBS,” see Rule 4(c) Report at 18 (ECF 30), nor that the vaccine caused any injury, id. at 19–20. The government accordingly “question[ed] the reasonable basis of this claim.” Id. at 21 n.6. In a November 2022 status conference, the Special Master shared “various concerns in this case” with Petitioner. Order (ECF 34). She ordered Petitioner to obtain “a report from a treater or an expert witness addressing them.” Id. Her order identified several issues the report was supposed to cover — including whether Mr. Honeycutt developed GBS — and provided a March 2023 deadline. Id. Petitioner never filed an expert report. After two extensions of time, Petitioner represented in an August 22, 2023 status report that she had “found a qualified expert to review the material and answer the questions this Court has regarding the claim,” but had not yet obtained the expert’s report. Status Report at 3 (ECF 40). Petitioner communicated with her expert and filed two additional submissions, both of which the Special Master struck from the record. See Order (ECF 43) (striking ECF 42); Order (ECF 45) (striking ECF 44). The parties filed a stipulation of dismissal in December 2023. See Stipulation of Dismissal (ECF 47). Petitioner’s counsel then sought fees. Fee Mot. (ECF 50); Resp. to Fee Mot. (ECF 52); Reply (ECF 53).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Honeycutt v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/honeycutt-v-secretary-of-health-and-human-services-uscfc-2026.